At HanAll, our mission is to make a meaningful contribution to patients’ quality of life by improving medical therapies.
Our global team is dedicated to transformative science, taking risks for innovation and serving patients.
HanAll aims to become a global pharmaceutical innovator with further expansion into multiple therapeutic areas
including oncology, immunology, neurology and ophthalmology.
This program is open for physicians trained in Indonesia only.
More about our Fellowship Program class of September 2022
Two Indonesian Doctors Join in HanAll's Biopharmaceutical Program (viva.co.id)